BioProcess International is part of the Informa Connect Division of Informa PLC
Informa PLC
|
ABOUT US
|
INVESTOR RELATIONS
|
TALENT
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
About
Subscribe
Contribute
Subscribe
Subscribe
Upstream
Related Topics
Bioreactors
Expression Platforms
Biochemicals/Raw Materials
Cell Culture Media
Microbial Cell Culture
Perfusion Cell Culture
See all
Downstream
Related Topics
Filtration
Viral Clearance
Separation/Purification
Chromatography
See all
Manufacturing
Related Topics
Biosimilars
Continuous Bioprocessing
Facility Design/Engineering
Formulation
Single Use
Fill/Finish
Information Technology
Recent in
Manufacturing
See all
thumbnail
Information Technology
Artificial Intelligence in the Biopharmaceutical Industry: Treacherous or Transformative?
Artificial Intelligence in the Biopharmaceutical Industry: Treacherous or Transformative?
by
Toni Manzano,
William Whitford
May 10, 2024
Monoclonal Antibody Productivity
Single Use
A Fully Single-Use Downstream Process for Monoclonal Antibodies
A Fully Single-Use Downstream Process for Monoclonal Antibodies
by
Shunsuke Shiina,
Neha Saxena
and 1 more
Apr 17, 2024
Analytical
Related Topics
QA/QC
Cell Line Development
PAT
Product Characterization
Bioanalytical Methods
Process Development
Assays
Recent in
Analytical
See all
thumbnail
Process Development
Scaling To Meet Demand Across the Life Cycle of a Recombinant Protein
Scaling To Meet Demand Across the Life Cycle of a Recombinant Protein
by
Pramthesh Patel
May 15, 2024
Stable Cell-Line Transfection
Cell Line Development
A Strategy for Sequence-Variant Control Leveraging Next-Generation Sequencing of Plasmid DNA Used for Stable Cell-Line Transfection
A Strategy for Sequence-Variant Control Leveraging Next-Generation Sequencing of Plasmid DNA Used for Stable Cell-Line Transfection
by
Shuai Wang,
Dujuan Lian
and 7 more
May 14, 2024
Business
Related Topics
Bioregions
Careers & Training
Contract Services
Economics
Pre-Clinical & Clinical Trials
Risk Management
Intellectual Property
Regulatory Affairs
Recent in
Business
See all
business man in choppy waters
Economics
Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology Companies amid Market Turmoil
Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology Companies amid Market Turmoil
by
Daniel Lofaso
May 10, 2024
Therapeutic Modalities
Related Topics
Cell Therapies
Gene Therapies
MAb
Emerging Therapeutics
Personalized Medicine
Large Molecule Development
Vaccines
Recent in
Therapeutic Modalities
See all
thumbnail
Cell Therapies
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control
Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control
by
Brent Morse,
Alicja Fiedorowicz
May 10, 2024
thumbnail
Gene Therapies
Bringing Your Cell and Gene Therapy Offerings to Market
Bringing Your Cell and Gene Therapy Offerings to Market
by
Stan Bonn
May 7, 2024
BioProcess Insider
Related Topics
Deal-Making
Facilities & Capacity
Global Markets
Regulations
Therapeutic Class
Upstream & Downstream Processing
Webcasts
BioProcess Insider Podcasts
Recent in
BioProcess Insider
See all
thumbnail
Deal Making
J&J expands immunotherapy portfolio with $850m Proteologix buy
J&J expands immunotherapy portfolio with $850m Proteologix buy
by
Shreeyashi Ojha
May 17, 2024
2 Min Read
thumbnail
Facilities & Capacity
Bolt Bio cuts workforce by 50% to refocus pipeline
Bolt Bio cuts workforce by 50% to refocus pipeline
by
Millie Nelson
May 17, 2024
2 Min Read
Home
Bioprocess Insider
Facilities & Capacity
Facilities & Capacity
Lonza building capacity for Gamida’s bone marrow transplant
Facilities & Capacity
Lonza building capacity for Gamida’s bone marrow transplant
Lonza building capacity for Gamida’s bone marrow transplant
by
Dan Stanton
Jun 19, 2019
|
2 Min Read
Middle class: Lonza on the flexibility of midscale biomanufacturing
Facilities & Capacity
Middle class: Lonza on the flexibility of midscale biomanufacturing
Middle class: Lonza on the flexibility of midscale biomanufacturing
by
Dan Stanton
Jun 14, 2019
3 Min Read
Fujifilm tackles buffer bottleneck at $10m continuous processing plant
Upstream & Downstream Processing
Fujifilm tackles buffer bottleneck at $10m continuous processing plant
Fujifilm tackles buffer bottleneck at $10m continuous processing plant
by
Dan Stanton
Jun 14, 2019
2 Min Read
Hitachi supplying gene therapy Zynteglo for bluebird in EU
Facilities & Capacity
Hitachi supplying gene therapy Zynteglo for bluebird in EU
Hitachi supplying gene therapy Zynteglo for bluebird in EU
by
BPI Staff
Jun 13, 2019
2 Min Read
Californian sun and $1.5m investment help ATUM go green
Facilities & Capacity
Californian sun and $1.5m investment help ATUM go green
Californian sun and $1.5m investment help ATUM go green
by
Dan Stanton
Jun 12, 2019
2 Min Read
Inside Jefferson: $7m bioprocess training institute opens in PA
Upstream & Downstream Processing
Inside Jefferson: $7m bioprocess training institute opens in PA
Inside Jefferson: $7m bioprocess training institute opens in PA
by
Dan Stanton
Jun 12, 2019
3 Min Read
Facilities & Capacity
Bavarian Nordic considers turning CMO as it builds out network
Bavarian Nordic considers turning CMO as it builds out network
May 29, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
REGENXBIO building Maryland AAV plant to support gene therapies
REGENXBIO building Maryland AAV plant to support gene therapies
May 22, 2019
|
2 Min Read
by
Dan Stanton
Global Markets
WuXi scouts single-use site for Chinese vaccine joint venture
WuXi scouts single-use site for Chinese vaccine joint venture
May 22, 2019
|
2 Min Read
by
Dan Stanton
Upstream & Downstream Processing
OPUS focus: Repligen expands to support chromatography demand
OPUS focus: Repligen expands to support chromatography demand
May 20, 2019
|
2 Min Read
by
Dan Stanton
Global Markets
Training and ‘sea turtles’ support WuXi Biologics’ growing China footprint
Training and ‘sea turtles’ support WuXi Biologics’ growing China footprint
May 17, 2019
|
3 Min Read
by
Dan Stanton
Therapeutic Class
ElevateBio proposes centralized model for cell & gene startups
ElevateBio proposes centralized model for cell & gene startups
May 15, 2019
|
2 Min Read
by
Dan Stanton
Deal Making
CDMO round-up: News from Patheon, Samsung and Sekisui
CDMO round-up: News from Patheon, Samsung and Sekisui
May 15, 2019
|
3 Min Read
by
BPI Staff
Facilities & Capacity
Pfizer opens $200m clinical manufacturing plant in MA
Pfizer opens $200m clinical manufacturing plant in MA
May 15, 2019
|
1 Min Read
by
Dan Stanton
Facilities & Capacity
Vibalogics $1.35m expansion feeds ‘booming’ viral vector demand
Vibalogics $1.35m expansion feeds ‘booming’ viral vector demand
May 10, 2019
|
1 Min Read
by
BPI Staff
Facilities & Capacity
Merck injects $1bn into Virginia site to support HPV vaccines
Merck injects $1bn into Virginia site to support HPV vaccines
May 7, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
Buoyed by CGT growth, Bio-Techne plans plant to supply $200m of reagents
Buoyed by CGT growth, Bio-Techne plans plant to supply $200m of reagents
May 7, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
CDMO Aldevron add 1,000L microbial capacity in Madison
CDMO Aldevron add 1,000L microbial capacity in Madison
May 6, 2019
|
2 Min Read
by
Dan Stanton
Deal Making
Alector inks strategic deal with Lonza for early-phase candidates
Alector inks strategic deal with Lonza for early-phase candidates
May 6, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
Fujifilm CDMO expands further in UK with BioCampus
Fujifilm CDMO expands further in UK with BioCampus
May 3, 2019
|
2 Min Read
by
BPI Staff
Facilities & Capacity
Breathing space: Inhalable biologics interest prompts Intertek expansion
Breathing space: Inhalable biologics interest prompts Intertek expansion
May 3, 2019
|
2 Min Read
by
Gareth Macdonald
Facilities & Capacity
STC opens GMP biologics plant, eyes commercial and gene therapies
STC opens GMP biologics plant, eyes commercial and gene therapies
Apr 30, 2019
|
2 Min Read
by
Dan Stanton
Therapeutic Class
Thermo Fisher allots $125m to expand CDMO buy Brammer
Thermo Fisher allots $125m to expand CDMO buy Brammer
Apr 26, 2019
|
3 Min Read
by
Dan Stanton
Bioprocess Insider
GSK injects $100 in Montana plant to support Shingrix vaccine
GSK injects $100 in Montana plant to support Shingrix vaccine
Apr 26, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
Novartis prepped for ‘unprecedented’ Zolgensma demand
Novartis prepped for ‘unprecedented’ Zolgensma demand
Apr 25, 2019
|
3 Min Read
by
Dan Stanton
Facilities & Capacity
Gilead’s Kite building MD plant to support commercial CAR-Ts
Gilead’s Kite building MD plant to support commercial CAR-Ts
Apr 24, 2019
|
2 Min Read
by
Dan Stanton
Facilities & Capacity
Catalent’s Paragon plans second plant to support Sarepta pipeline
Catalent’s Paragon plans second plant to support Sarepta pipeline
Apr 19, 2019
|
2 Min Read
by
BPI Staff
Global Markets
Egg beater: Seqirus goes fully cell-based for seasonal flu vaccine
Egg beater: Seqirus goes fully cell-based for seasonal flu vaccine
Apr 19, 2019
|
3 Min Read
by
Dan Stanton
Facilities & Capacity
Celularity leases NJ plant to make its off-the-shelf stem cell therapies
Celularity leases NJ plant to make its off-the-shelf stem cell therapies
Apr 17, 2019
|
2 Min Read
by
Dan Stanton